Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Open-market sale Chief Executive Officer sold 14,075 shares at $4.58 ($64,464)
  2. 4 Open-market sale Chief Data Officer sold 5,342 shares at $4.58 ($24,466)
  3. 4 Open-market sale General Counsel sold 5,915 shares at $4.58 ($27,091)
  4. 4 Open-market sale Chief Information Officer sold 7,297 shares at $4.58 ($33,420)
  5. 4 Open-market sale Chief Scientific Officer sold 5,915 shares at $4.58 ($27,091)
  6. 4 Open-market sale Chief Financial Officer sold 5,915 shares at $4.58 ($27,091)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Planned sale Chief Information Officer sold 554 shares at $3.97 ($2,199)
  9. 4 Option exercise Director acquired 37,549 shares (option exercise)
  10. 4 Planned sale Director sold 34,211 shares at an average $6.74 ($230,469)
  11. 4 Planned sale General Counsel sold 29,591 shares at an average $6.80 ($201,133)
  12. 4 Planned sale Chief Information Officer sold 16,473 shares at an average $7.27 ($119,678)
  13. 4 Planned sale Chief Data Officer sold 13,419 shares at an average $7.42 ($99,565)
  14. 4 Planned sale Chief Financial Officer sold 2,431 shares at $8.06 ($19,594)
  15. 4 Open-market sale Director sold 100 shares at $7.69 ($769)
  16. 4 Open-market sale Chief Executive Officer sold 26,224 shares at $7.41 ($194,320)
  17. 4 Open-market sale Chief Financial Officer sold 5,730 shares at $7.41 ($42,459)
  18. 4 Open-market sale Director sold 93 shares at $7.12 ($662)
  19. 4 Open-market sale Director sold 95 shares at $7.32 ($695)
  20. 4 Open-market sale Chief Executive Officer sold 12,075 shares at $7.32 ($88,389)

Page 8 of 16 · 313 filings